Edward White
Stock Analyst at HC Wainwright & Co.
(1.85)
# 3,152
Out of 4,944 analysts
358
Total ratings
29.38%
Success rate
-8.04%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.29 | +352.99% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $9.40 | +80.85% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $6.69 | +124.22% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $2.16 | +177.78% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.62 | +887.65% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.75 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $7.56 | +958.54% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.35 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $2.47 | +709.72% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.50 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.70 | +332.43% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.95 | +259.71% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.83 | +860.38% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $9.36 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.64 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $27.12 | +102.80% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $12.97 | +293.22% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.87 | +43.74% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $4.06 | +1,279.31% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $10.58 | +193.01% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.84 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $6.07 | +11,432.13% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $23.62 | +27.04% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $0.94 | +1,181.64% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.29
Upside: +352.99%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $9.40
Upside: +80.85%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $6.69
Upside: +124.22%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $2.16
Upside: +177.78%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.62
Upside: +887.65%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.75
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $7.56
Upside: +958.54%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.35
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $2.47
Upside: +709.72%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.50
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.70
Upside: +332.43%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.95
Upside: +259.71%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.83
Upside: +860.38%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $9.36
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $27.12
Upside: +102.80%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $12.97
Upside: +293.22%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $4.87
Upside: +43.74%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $4.06
Upside: +1,279.31%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $10.58
Upside: +193.01%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.84
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $6.07
Upside: +11,432.13%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $23.62
Upside: +27.04%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $0.94
Upside: +1,181.64%